Recruiting NA HPV (Human Papillomavirus)-Associated

New treatment option for HPV (Human Papillomavirus)-Associated

Official title Parent Education About Human Papillomavirus (HPV)

ClinicalTrials.gov ID: NCT07447245

What this study is testing

What it's testing
Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide and is the primary cause of cervical cancer. According to World Health Organization (WHO) systems, there were approximately 660,000 new cases of cervical cancer and 350,000 deaths in 2022.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 11 to 49. Healthy volunteers may be eligible.

You may be able to join if

  • Parent must be between 18-49 years old
  • Parent must be a child aged 11-18
  • Parent must not have hearing or speech problems
  • Parent must be able to read and write in Turkish
  • Parent must agree to participate in the study

You likely can't join if

  • Parents of children who have received the HPV vaccine

The study team makes the final eligibility decision.

Where it's taking place

  • Konya, Turkey (Türkiye)

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 11 years to 49 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Konya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.